Open | $0.871 |
Close | $0.907 |
Volume / Avg. | 375.848K / 975.021K |
Day Range | 0.801 - 0.930 |
52 Wk Range | 0.500 - 5.870 |
Market Cap | $49.185M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 5.7% |
Days to Cover | 4.82 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.
Other companies in Cara Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Ocuphire Pharma (NASDAQ:OCUP).
The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Canaccord Genuity on Wednesday, March 6, 2024. The analyst firm set a price target for 10.00 expecting CARA to rise to within 12 months (a possible 1011.23% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $0.8999 last updated March 18, 2024 at 5:32 PM EDT.
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.